LASTACAFT

LASTACAFT is an FDA drug label for the active ingredient ALCAFTADINE manufactured by Allergan, Inc. administered by OPHTHALMIC. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220810.

Generic: ALCAFTADINE

Manufacturer: Allergan, Inc.

Product Type: HUMAN OTC DRUG

Route: OPHTHALMIC

Dosage Form:

NDC: 0023-4291

Application: NDA022134

Effective: 20220810

Active Ingredients: Active ingredient Alcaftadine 0.25%

Indications & Usage

Us e temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander

Dosage & Administration

Directions a dults and children 2 years of age and older: put 1 drop in the affected eye(s) once daily if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use c hildren under 2 years of age : consult a doctor

Contraindications

Not available.

Warnings

Warnings For external use only Do not use ■ if solution changes color or becomes cloudy ■ if you are sensitive to any ingredient in this product ■ to treat contact lens related irritation When using this product ■ do not touch tip of container to any surface to avoid contamination ■ remove contact lenses before use ■ wait at least 10 minutes before reinserting contact lenses after use ■ do not wear a contact lens if your eye is red Stop use and ask a doctor if you experience any of the following: ■ eye pain ■ changes in vision ■ increased redness of the eye ■ itching that worsens or lasts for more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Adverse Reactions